marketcaparena
Search

    CDXS

    CODEXIS, INC.

    Company overview

    Market capitalization
    $148.93M
    Employees
    146
    Latest publication
    2026-09-29
    About CODEXIS, INC.

    Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue14,915,000USD15,248,000USD38,915,000USD8,601,000USD15,328,000USD7,543,000USD21,460,000USD12,833,000USD
    Cost Of Revenue3,512,000USD3,312,000USD3,362,000USD2,465,000USD3,400,000USD2,732,000USD3,654,000USD4,317,000USD
    Gross Profit11,403,000USD11,936,000USD35,553,000USD6,136,000USD11,928,000USD4,811,000USD17,806,000USD8,516,000USD
    Research Development11,705,000USD10,310,000USD10,924,000USD13,868,000USD12,594,000USD12,942,000USD12,099,000USD11,505,000USD
    Selling General Administrative10,927,000USD9,779,000USD11,185,000USD11,217,000USD12,317,000USD12,355,000USD13,048,000USD13,568,000USD
    Total Operating Expenses22,632,000USD19,979,000USD21,588,000USD25,085,000USD24,790,000USD25,297,000USD25,147,000USD25,073,000USD
    Operating Income-11,229,000USD-8,042,999USD13,965,000USD-18,949,000USD-12,862,000USD-20,486,000USD-7,341,000USD-16,557,000USD
    Total Other Income Expense Net-766,000USD-625,000USD-4,346,000USD-658,000USD-400,000USD-191,000USD-3,032,000USD-4,073,000USD
    Interest Income535,000USD665,000USD656,000USD634,000USD584,000USD751,000USD940,000USD849,000USD
    Income Before Tax-11,995,000USD-8,668,000USD9,619,000USD-19,607,000USD-13,262,000USD-20,677,000USD-10,373,000USD-20,630,000USD
    Income Tax Expense10,000USD36,000USD18,000USD8,000USD10,000USD11,000USD3,000USD10,000USD
    Net Income-12,005,000USD-8,704,000USD9,601,000USD-19,615,000USD-13,272,000USD-20,688,000USD-10,376,000USD-20,640,000USD
    Interest Expense—1,290,000USD1,595,000USD1,292,000USD984,000USD942,000USD6,421,000USD4,922,000USD
    Net Interest Income—-625,000USD-940,000USD-658,000USD-400,000USD-191,000USD7,361,000USD-4,073,000USD
    Tax Provision—36,000USD18,000USD8,000USD10,000USD11,000USD3,000USD10,000USD
    Net Income From Continuing Ops—-8,704,000USD9,601,000USD-19,615,000USD-13,272,000USD-20,688,000USD-10,376,000USD-20,640,000USD
    Ebit—-8,042,999USD13,965,000USD-18,315,000USD-12,862,000USD-19,735,000USD-10,373,000USD-15,708,000USD
    Ebitda—-5,821,999USD16,188,000USD-16,221,000USD-10,834,000USD-17,826,000USD-8,282,000USD-13,684,000USD
    Depreciation And Amortization—2,221,000USD2,223,000USD2,094,000USD2,028,000USD1,909,000USD2,091,000USD2,024,000USD
    Reconciled Depreciation—2,221,000USD-821,000USD2,094,000USD2,066,000USD1,909,000USD-1,155,000USD2,024,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue70,387,000USD59,345,000USD70,143,000USD138,590,000USD104,754,000USD69,056,000USD68,458,000USD60,594,000USD
    Cost Of Revenue9,338,000USD16,288,000USD12,809,000USD38,033,000USD22,209,000USD13,742,000USD15,632,000USD12,620,000USD
    Gross Profit61,049,000USD43,057,000USD57,334,000USD100,557,000USD82,545,000USD55,314,000USD52,826,000USD47,974,000USD
    Research Development52,307,000USD46,263,000USD58,885,000USD80,099,000USD55,919,000USD44,185,000USD33,873,000USD29,978,000USD
    Selling General Administrative47,074,000USD55,148,000USD52,950,000USD51,872,000USD49,323,000USD35,049,000USD31,502,000USD29,291,000USD
    Total Operating Expenses99,381,000USD101,576,000USD125,403,000USD135,438,000USD105,242,000USD79,234,000USD65,375,000USD59,269,000USD
    Operating Income-38,332,000USD-58,519,000USD-68,069,000USD-34,881,000USD-22,697,000USD-23,920,000USD-12,549,000USD-11,295,000USD
    Interest Income2,625,000USD3,670,000USD4,089,000USD1,441,000USD459,000USD405,000USD1,287,000USD671,000USD
    Interest Expense4,813,000USD10,393,000USD12,274,000USD1,441,000USD7,554,000USD4,803,000USD5,188,000USD671,000USD
    Net Interest Income-2,188,000USD3,670,000USD4,089,000USD1,441,000USD459,000USD405,000USD1,287,000USD671,000USD
    Income Before Tax-43,927,000USD-65,242,000USD-76,171,000USD-33,316,000USD-21,090,000USD-23,671,000USD-11,918,000USD-10,915,000USD
    Income Tax Expense47,000USD34,000USD69,000USD276,000USD189,000USD339,000USD17,000USD-37,000USD
    Tax Provision47,000USD34,000USD185,000USD276,000USD189,000USD339,000USD17,000USD-37,000USD
    Net Income-43,974,000USD-65,276,000USD-76,240,000USD-33,592,000USD-21,279,000USD-24,010,000USD-11,935,000USD-10,878,000USD
    Net Income From Continuing Ops-43,974,000USD-65,276,000USD-81,652,000USD-33,592,000USD-21,279,000USD-24,010,000USD-11,935,000USD-10,878,000USD
    Ebit-39,114,000USD-58,354,000USD-54,801,000USD-31,714,000USD-22,697,000USD-23,920,000USD-12,549,000USD-11,295,000USD
    Ebitda-33,866,000USD-58,519,000USD-49,283,000USD-26,312,000USD-16,750,000USD-19,366,000USD-7,992,000USD-10,148,000USD
    Depreciation And Amortization5,248,000USD-165,000USD5,518,000USD5,402,000USD5,947,000USD4,554,000USD4,557,000USD1,147,000USD
    Reconciled Depreciation5,248,000USD4,946,000USD10,621,000USD10,251,000USD5,947,000USD4,554,000USD4,557,000USD1,147,000USD
    Total Other Income Expense Net-5,595,000USD-6,723,000USD-8,102,000USD1,565,000USD1,607,000USD249,000USD631,000USD-291,000USD
    Selling And Marketing Expenses——300,000USD300,000USD300,000USD300,000USD500,000USD500,000USD
    Unclassified Operating Expenses——13,268,000USD3,167,000USD————
    Net Income Applicable To Common Shares———-33,592,000USD-21,279,000USD-24,010,000USD-11,935,000USD-10,878,000USD
    Non Operating Income Net Other————1,607,000USD249,000USD631,000USD380,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets120,055,000USD129,370,000USD147,797,000USD123,961,000USD138,246,000USD128,887,000USD149,011,000USD148,183,000USD
    Cash And Equivalents27,172,000USD———————
    Cash And Short Term Investments54,918,000USD65,565,000USD78,209,000USD59,186,000USD66,330,000USD59,781,000USD73,458,000USD90,255,000USD
    Short Term Investments27,746,000USD28,569,000USD27,416,000USD33,350,000USD39,569,000USD41,462,000USD54,194,000USD52,803,000USD
    Total Current Assets71,916,000USD79,649,000USD96,816,000USD76,192,000USD88,729,000USD77,808,000USD98,772,000USD112,902,000USD
    Other Current Assets500,000USD4,057,000USD6,061,000USD5,337,000USD3,971,000USD4,659,000USD4,631,000USD4,004,000USD
    Other Non Current Assets1,041,000USD———————
    Total Liabilities87,097,000USD———————
    Total Current Liabilities23,511,000USD14,850,000USD25,317,000USD18,475,000USD15,237,000USD20,901,000USD23,648,000USD35,129,000USD
    Other Current Liabilities3,365,000USD———————
    Other Non Current Liabilities1,350,000USD———————
    Total Stockholder Equity32,958,000USD43,234,000USD50,529,000USD38,544,000USD55,631,000USD49,629,000USD66,927,000USD73,400,000USD
    Total Equity Including Noncontrolling Interest32,958,000USD———————
    Short Long Term Debt7,057,000USD———————
    Long Term Debt33,819,000USD40,483,000USD40,105,000USD39,729,000USD39,373,000USD29,186,000USD28,905,000USD28,631,000USD
    Deferred Revenue862,000USD———————
    Deferred Revenue Non Current0USD———————
    Inventory1,602,000USD2,000,000USD1,817,000USD1,936,000USD1,945,000USD1,781,000USD1,799,000USD2,103,000USD
    Property Plant Equipment Net40,525,000USD42,154,000USD43,525,000USD40,534,000USD42,244,000USD43,789,000USD42,897,000USD24,038,000USD
    Goodwill2,463,000USD———————
    Accounts Payable2,609,000USD2,127,000USD1,554,000USD2,425,000USD1,468,000USD6,046,000USD2,838,000USD4,212,000USD
    Short Term Debt3,294,000USD3,302,000USD2,944,000USD3,091,000USD3,001,000USD2,913,000USD2,827,000USD4,081,000USD
    Common Stock9,000USD9,000USD9,000USD9,000USD9,000USD8,000USD8,000USD8,000USD
    Retained Earnings-627,489,000USD-615,484,000USD-606,780,000USD-616,381,000USD-596,766,000USD-583,494,000USD-562,806,000USD-552,430,000USD
    Accumulated Other Comprehensive Income-13,000USD-11,000USD8,000USD12,000USD-3,000USD14,000USD52,000USD126,000USD
    Total Liab—86,136,000USD97,268,000USD85,417,000USD82,615,000USD79,258,000USD82,084,000USD74,783,000USD
    Other Current Liab—8,555,000USD13,810,000USD12,663,000USD10,668,000USD11,504,000USD17,633,000USD16,825,000USD
    Capital Stock—9,000USD9,000USD9,000USD9,000USD8,000USD8,000USD8,000USD
    Good Will—2,463,000USD2,463,000USD2,463,000USD2,463,000USD2,463,000USD2,463,000USD2,463,000USD
    Cash—36,996,000USD50,793,000USD25,836,000USD26,761,000USD18,319,000USD19,264,000USD37,452,000USD
    Current Deferred Revenue—866,000USD7,009,000USD296,000USD100,000USD438,000USD350,000USD10,011,000USD
    Net Debt—35,907,000USD22,415,000USD42,785,000USD42,219,000USD41,178,000USD40,631,000USD4,394,000USD
    Short Long Term Debt Total—72,903,000USD73,208,000USD68,621,000USD68,980,000USD59,497,000USD59,895,000USD41,846,000USD
    Long Term Investments—2,498,000USD2,498,000USD2,798,000USD2,798,000USD2,798,000USD2,798,000USD5,790,000USD
    Net Receivables—8,026,999USD10,729,000USD9,733,000USD16,483,000USD11,587,000USD18,884,000USD16,540,000USD
    Property Plant Equipment Gross—88,077,000USD88,767,000USD84,542,000USD85,022,000USD85,361,000USD83,832,000USD64,761,000USD
    Common Stock Shares Outstanding—90,768,000shares90,906,000shares90,251,000shares85,389,000shares82,410,000shares81,300,000shares72,032,000shares
    Non Current Assets Total—49,721,000USD50,981,000USD47,769,000USD49,517,000USD51,079,000USD50,239,000USD35,281,000USD
    Non Current Liabilities Total—71,286,000USD71,951,000USD66,942,000USD67,378,000USD58,357,000USD58,436,000USD39,654,000USD
    Non Current Liabilities Other—1,335,000USD1,327,000USD1,312,000USD1,299,000USD1,283,000USD1,268,000USD1,279,000USD
    Non Currrent Assets Other—594,000USD2,495,000USD512,000USD2,012,000USD2,029,000USD2,081,000USD2,990,000USD
    Net Working Capital—64,799,000USD71,499,000USD57,717,000USD73,492,000USD56,907,000USD75,124,000USD77,773,000USD
    Unclassified Non Current Assets—2,012,000USD—1,462,000USD————
    Unclassified Non Current Liabilities—29,468,000USD30,519,000USD25,901,000USD26,706,000USD27,888,000USD28,263,000USD9,744,000USD
    Unclassified Equity—658,711,000USD657,283,000USD654,895,000USD652,382,000USD633,093,000USD629,665,000USD625,688,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets147,797,000USD149,011,000USD136,561,000USD250,393,000USD246,383,000USD221,646,000USD149,073,000USD78,283,000USD
    Other Current Assets6,061,000USD4,631,000USD5,737,000USD6,008,000USD6,279,000USD4,054,000USD3,181,000USD1,068,000USD
    Total Liab97,268,000USD82,084,000USD49,946,000USD105,596,000USD81,992,000USD51,543,000USD43,556,000USD21,977,000USD
    Total Stockholder Equity50,529,000USD66,927,000USD86,615,000USD144,797,000USD164,391,000USD170,103,000USD105,517,000USD56,306,000USD
    Other Current Liab13,810,000USD17,633,000USD15,981,000USD26,732,000USD23,697,000USD17,560,000USD11,543,000USD9,702,000USD
    Common Stock9,000USD8,000USD7,000USD6,000USD6,000USD6,000USD6,000USD5,000USD
    Capital Stock9,000USD8,000USD7,000USD6,000USD6,000USD6,000USD6,000USD5,000USD
    Retained Earnings-606,780,000USD-562,806,000USD-497,530,000USD-421,290,000USD-387,698,000USD-366,419,000USD-342,409,000USD-330,474,000USD
    Good Will2,463,000USD2,463,000USD2,463,000USD3,241,000USD3,241,000USD3,241,000USD3,241,000USD3,241,000USD
    Cash50,793,000USD19,264,000USD65,116,000USD113,984,000USD116,797,000USD149,117,000USD90,498,000USD53,039,000USD
    Cash And Short Term Investments78,209,000USD73,458,000USD65,116,000USD113,984,000USD116,797,000USD150,117,000USD90,498,000USD53,039,000USD
    Total Current Assets96,816,000USD98,772,000USD93,466,000USD162,894,000USD161,888,000USD184,423,000USD114,205,000USD67,198,000USD
    Total Current Liabilities25,317,000USD23,648,000USD35,830,000USD49,066,000USD33,371,000USD24,981,000USD15,388,000USD17,113,000USD
    Current Deferred Revenue7,009,000USD350,000USD10,121,000USD13,728,000USD2,586,000USD1,824,000USD57,000USD3,936,000USD
    Net Debt22,415,000USD40,631,000USD-49,092,000USD-70,346,000USD-69,143,000USD-124,166,000USD-64,380,000USD-52,978,000USD
    Short Term Debt2,944,000USD2,827,000USD3,781,000USD5,360,000USD4,093,000USD2,627,000USD1,167,000USD425,000USD
    Short Long Term Debt Total73,208,000USD59,895,000USD16,024,000USD43,638,000USD47,654,000USD24,951,000USD26,118,000USD486,000USD
    Long Term Debt40,105,000USD28,905,000USD——————
    Long Term Investments2,498,000USD2,798,000USD9,700,000USD20,510,000USD14,002,000USD1,450,000USD0USD588,000USD
    Short Term Investments27,416,000USD54,194,000USD0USD—0USD1,000,000USD——
    Net Receivables10,729,000USD18,884,000USD19,928,000USD40,873,000USD37,652,000USD29,288,000USD20,155,000USD12,502,000USD
    Inventory1,817,000USD1,799,000USD2,685,000USD2,029,000USD1,160,000USD964,000USD371,000USD589,000USD
    Accounts Payable1,554,000USD2,838,000USD5,947,000USD3,246,000USD2,995,000USD2,970,000USD2,621,000USD3,050,000USD
    Property Plant Equipment Net43,525,000USD42,897,000USD28,624,000USD61,877,000USD65,457,000USD31,176,000USD30,387,000USD4,759,000USD
    Property Plant Equipment Gross88,767,000USD83,832,000USD67,935,000USD61,877,000USD65,457,000USD31,176,000USD30,387,000USD4,759,000USD
    Accumulated Other Comprehensive Income8,000USD52,000USD0USD———-33,251,000USD-33,093,000USD
    Common Stock Shares Outstanding87,142,000shares73,408,000shares68,131,000shares65,343,999shares64,568,000shares59,360,000shares56,525,000shares52,205,000shares
    Non Current Assets Total50,981,000USD50,239,000USD43,095,000USD87,499,000USD84,495,000USD37,223,000USD34,868,000USD11,085,000USD
    Non Current Liabilities Total71,951,000USD58,436,000USD14,116,000USD56,530,000USD48,621,000USD26,562,000USD28,168,000USD4,864,000USD
    Non Current Liabilities Other1,327,000USD1,268,000USD1,233,000USD1,371,000USD1,311,000USD26,562,000USD28,168,000USD4,803,000USD
    Non Currrent Assets Other2,495,000USD2,081,000USD2,308,000USD1,871,000USD1,795,000USD1,356,000USD1,240,000USD2,497,000USD
    Net Working Capital71,499,000USD75,124,000USD57,636,000USD113,828,000USD128,517,000USD159,442,000USD98,817,000USD50,085,000USD
    Unclassified Non Current Liabilities30,519,000USD28,263,000USD12,883,000USD36,888,000USD42,194,000USD-4,328,000USD-3,217,000USD-4,784,000USD
    Unclassified Equity657,283,000USD629,665,000USD584,131,000USD566,075,000USD552,077,000USD536,510,000USD481,165,000USD419,863,000USD
    Deferred Long Term Liab———19,000USD56,000USD90,000USD—42,000USD
    Other Liab———18,252,000USD5,060,000USD4,238,000USD3,217,000USD4,803,000USD
    Other Assets———1,871,000USD1,795,000USD1,356,000USD1,240,000USD2,497,000USD
    Net Tangible Assets———141,556,000USD161,150,000USD166,862,000USD102,276,000USD53,065,000USD
    Unclassified Non Current Assets———-1,871,000USD-1,795,000USD-1,356,000USD-1,240,000USD-2,497,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation2,496,000USD
    Stock Based Compensation3,011,000USD
    Change To Inventory215,000USD
    Change To Liabilities-670,000USD
    Change In Working Capital3,669,000USD
    Operating Cash Flow-22,793,000USD
    Capital Expenditures-1,074,000USD
    Unclassified Investing Cash Flow138,000USD
    Investing Cash Flow-936,000USD
    Net Debt Issuance0USD
    Common Stock Issuance148,000USD
    Unclassified Financing Cash Flow-96,000USD
    Financing Cash Flow52,000USD
    Change In Cash-23,677,000USD
    End Cash Flow29,206,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-8,704,000USD9,601,000USD-19,615,000USD-13,272,000USD-20,688,000USD-10,376,000USD-20,640,000USD-22,755,000USD
    Depreciation1,286,000USD2,071,000USD2,056,000USD1,340,000USD1,909,000USD-1,155,000USD-315,000USD2,052,000USD
    Stock Based Compensation1,428,000USD2,200,000USD2,513,000USD2,532,000USD2,379,000USD2,526,000USD2,708,000USD4,682,000USD
    Other Non Cash Items1,073,000USD531,000USD2,574,000USD753,000USD-165,000USD6,161,000USD5,990,000USD6,000USD
    Change To Account Receivables2,479,000USD-839,000USD6,706,000USD-4,786,000USD7,426,000USD-1,566,000USD-4,319,000USD1,566,000USD
    Change To Inventory-183,000USD118,000USD9,000USD-164,000USD18,000USD304,000USD129,000USD209,000USD
    Change In Working Capital-8,233,000USD5,689,000USD7,282,000USD-9,320,000USD2,767,000USD-13,624,000USD-728,000USD3,847,000USD
    Total Cash From Operating Activities-13,150,000USD20,092,000USD-7,703,000USD-17,967,000USD-13,798,000USD-16,468,000USD-12,985,000USD-12,168,000USD
    Capital Expenditures-176,000USD-520,000USD-182,000USD-2,513,000USD-1,256,000USD-1,774,000USD-1,006,000USD-395,000USD
    Free Cash Flow-13,326,000USD19,572,000USD-7,885,000USD-20,480,000USD-15,054,000USD-18,242,000USD-13,991,000USD-12,563,000USD
    Investments-935,000USD6,233,000USD6,387,000USD-367,000USD11,769,000USD-2,863,000USD1,533,000USD-27,087,000USD
    Total Cashflows From Investing Activities-1,111,000USD5,713,000USD6,387,000USD-367,000USD11,769,000USD-2,863,000USD1,533,000USD-27,087,000USD
    Total Cash From Financing Activities-14,000USD180,000USD-111,000USD26,774,000USD1,085,000USD1,132,000USD30,306,000USD-197,000USD
    Change In Cash-14,275,000USD25,985,000USD3,543,000USD8,440,000USD-944,000USD-18,199,000USD18,854,000USD-39,452,000USD
    Begin Period Cash Flow52,883,000USD26,898,000USD22,293,000USD19,885,000USD20,829,000USD39,028,000USD20,174,000USD58,564,000USD
    End Period Cash Flow38,608,000USD52,883,000USD25,836,000USD28,325,000USD19,885,000USD20,829,000USD39,028,000USD19,112,000USD
    Other Cashflows From Financing Activities-14,000USD180,000USD-111,000USD-3,000USD1,085,000USD30,654,000USD-1,014,000USD-197,000USD
    Net Borrowings—0USD0USD9,897,000USD0USD0USD0USD—
    Issuance Of Capital Stock—-1,000USD0USD——-1,000USD31,320,000USD0USD
    Other Cashflows From Investing Activities—-4,000USD5,000USD3,000USD1,000USD3,000USD84,000USD-26,692,000USD
    Unclassified Operating Cash Flow——-2,513,000USD—————
    Unclassified Investing Cash Flow———2,510,000USD1,255,000USD1,771,000USD—27,087,000USD
    Unclassified Financing Cash Flow———16,880,000USD—-29,521,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-43,974,000USD-65,276,000USD-76,240,000USD-33,592,000USD-21,279,000USD-24,010,000USD-11,935,000USD-10,878,000USD
    Depreciation5,248,000USD4,946,000USD9,923,000USD10,251,000USD5,947,000USD4,554,000USD4,557,000USD1,147,000USD
    Stock Based Compensation9,624,000USD13,087,000USD9,971,000USD14,531,000USD11,593,000USD7,728,000USD6,943,000USD7,889,000USD
    Other Non Cash Items3,308,000USD9,849,000USD21,925,000USD-1,478,000USD-19,000USD55,000USD525,000USD91,000USD
    Change To Account Receivables8,507,000USD1,252,000USD20,247,000USD-3,225,000USD-15,571,000USD-12,321,000USD2,522,000USD960,000USD
    Change To Inventory-19,000USD886,000USD-656,000USD-869,000USD-196,000USD-593,000USD217,000USD447,000USD
    Change In Working Capital6,418,000USD-12,016,000USD-18,217,000USD21,572,000USD-7,624,000USD-3,891,000USD-12,650,000USD-12,343,000USD
    Total Cash From Operating Activities-19,376,000USD-49,410,000USD-52,638,000USD11,284,000USD-14,267,000USD-16,464,000USD-12,560,000USD-14,094,000USD
    Capital Expenditures-4,471,000USD-4,305,000USD-4,418,000USD-8,307,000USD-13,828,000USD-3,748,000USD-3,730,000USD-2,768,000USD
    Free Cash Flow-23,847,000USD-53,715,000USD-57,056,000USD2,977,000USD-28,095,000USD-20,212,000USD-16,290,000USD-16,862,000USD
    Investments27,968,000USD-56,980,000USD-5,929,000USD-13,578,000USD-7,630,000USD-2,000,000USD62,000USD-2,766,000USD
    Total Cashflows From Investing Activities23,502,000USD-56,980,000USD-4,858,000USD-13,578,000USD-21,422,000USD-5,748,000USD-3,665,000USD-2,766,000USD
    Net Borrowings9,897,000USD29,521,000USD0USD0USD0USD-60,000USD-242,000USD-238,000USD
    Total Cash From Financing Activities27,928,000USD60,522,000USD8,167,000USD-575,000USD3,767,000USD80,808,000USD53,961,000USD38,569,000USD
    Issuance Of Capital Stock17,267,000USD31,319,000USD8,652,000USD1,540,000USD0USD86,250,000USD50,000,000USD37,497,000USD
    Change In Cash32,054,000USD-45,868,000USD-49,329,000USD-2,869,000USD-31,922,000USD58,596,000USD37,736,000USD21,709,000USD
    Begin Period Cash Flow20,829,000USD66,697,000USD116,026,000USD118,895,000USD150,817,000USD92,221,000USD54,485,000USD32,776,000USD
    End Period Cash Flow52,883,000USD20,829,000USD66,697,000USD116,026,000USD118,895,000USD150,817,000USD92,221,000USD54,485,000USD
    Other Cashflows From Investing Activities5,000USD87,000USD-440,000USD29,000USD36,000USD-2,000,000USD3,000USD2,000USD
    Other Cashflows From Financing Activities27,928,000USD-318,000USD-485,000USD-1,488,000USD-1,206,000USD-5,382,000USD4,203,000USD1,310,000USD
    Unclassified Financing Cash Flow-27,164,000USD—9,056,000USD2,401,000USD6,179,000USD88,764,000USD55,700,000USD40,687,000USD
    Unclassified Investing Cash Flow—4,218,000USD5,929,000USD8,278,000USD—2,000,000USD—2,766,000USD
    Sale Purchase Of Stock——-404,000USD-1,488,000USD-1,206,000USD-1,257,000USD-2,850,000USD-3,190,000USD
    Change To Liabilities———24,725,000USD1,568,000USD3,690,000USD567,000USD-926,000USD
    Cash And Cash Equivalents Changes————-31,922,000USD58,596,000USD37,736,000USD21,709,000USD
    Unclassified Operating Cash Flow————-2,885,000USD———
    Dividends Paid—————-1,257,000USD-2,850,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyAmericas7,861,000USD0001200375-26-000012
    Q1 2026Quarterly · 2026-03-31GeographyAPAC5,329,000USD0001200375-26-000012
    Q1 2026Quarterly · 2026-03-31GeographyEMEA2,058,000USD0001200375-26-000012
    Q1 2026Quarterly · 2026-03-31ProductProduct7,191,000USD0001200375-26-000012
    Q1 2026Quarterly · 2026-03-31ProductResearchand Development Revenue8,057,000USD0001200375-26-000012
    FY 2025Yearly · 2025-12-31GeographyAmericas43,537,000USD0001200375-26-000006
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific17,558,000USD0001200375-26-000006
    FY 2025Yearly · 2025-12-31GeographyEMEA9,292,000USD0001200375-26-000006
    FY 2025Yearly · 2025-12-31ProductProduct26,028,000USD0001200375-26-000006
    FY 2025Yearly · 2025-12-31ProductResearch And Development Revenue44,359,000USD0001200375-26-000006
    Q3 2025Quarterly · 2025-09-30GeographyAmericas1,567,000USD0001200375-25-000016
    Q3 2025Quarterly · 2025-09-30GeographyAPAC6,062,000USD0001200375-25-000016
    Q3 2025Quarterly · 2025-09-30GeographyEMEA972,000USD0001200375-25-000016
    Q3 2025Quarterly · 2025-09-30ProductProduct6,807,000USD0001200375-25-000016
    Q3 2025Quarterly · 2025-09-30ProductResearchand Development Revenue1,794,000USD0001200375-25-000016
    Q2 2025Quarterly · 2025-06-30GeographyAmericas6,352,000USD0001200375-25-000012
    Q2 2025Quarterly · 2025-06-30GeographyAPAC6,580,000USD0001200375-25-000012
    Q2 2025Quarterly · 2025-06-30GeographyEMEA2,396,000USD0001200375-25-000012
    Q2 2025Quarterly · 2025-06-30ProductProduct7,380,000USD0001200375-25-000012
    Q2 2025Quarterly · 2025-06-30ProductResearchand Development Revenue7,948,000USD0001200375-25-000012
    Q1 2025Quarterly · 2025-03-31GeographyAmericas2,088,000USD0001200375-26-000012
    Q1 2025Quarterly · 2025-03-31GeographyAPAC1,536,000USD0001200375-26-000012
    Q1 2025Quarterly · 2025-03-31GeographyEMEA3,919,000USD0001200375-26-000012
    Q1 2025Quarterly · 2025-03-31ProductProduct6,059,000USD0001200375-26-000012
    Q1 2025Quarterly · 2025-03-31ProductResearchand Development Revenue1,484,000USD0001200375-26-000012
    FY 2024Yearly · 2024-12-31GeographyAmericas21,278,000USD0001200375-26-000006
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific27,708,000USD0001200375-26-000006
    FY 2024Yearly · 2024-12-31GeographyEMEA10,359,000USD0001200375-26-000006
    FY 2024Yearly · 2024-12-31ProductProduct36,786,000USD0001200375-26-000006
    FY 2024Yearly · 2024-12-31ProductResearch And Development Revenue22,559,000USD0001200375-26-000006
    Q3 2024Quarterly · 2024-09-30GeographyAmericas1,534,000USD0001200375-25-000016
    Q3 2024Quarterly · 2024-09-30GeographyAPAC9,070,000USD0001200375-25-000016
    Q3 2024Quarterly · 2024-09-30GeographyEMEA2,229,000USD0001200375-25-000016
    Q3 2024Quarterly · 2024-09-30ProductProduct11,158,000USD0001200375-25-000016
    Q3 2024Quarterly · 2024-09-30ProductResearchand Development Revenue1,675,000USD0001200375-25-000016
    Q2 2024Quarterly · 2024-06-30GeographyAmericas1,046,000USD0001200375-25-000012
    Q2 2024Quarterly · 2024-06-30GeographyAPAC4,966,000USD0001200375-25-000012
    Q2 2024Quarterly · 2024-06-30GeographyEMEA1,967,000USD0001200375-25-000012
    Q2 2024Quarterly · 2024-06-30ProductProduct6,259,000USD0001200375-25-000012
    Q2 2024Quarterly · 2024-06-30ProductResearchand Development Revenue1,720,000USD0001200375-25-000012
    Q1 2024Quarterly · 2024-03-31GeographyAmericas7,244,000USD0001200375-25-000006
    Q1 2024Quarterly · 2024-03-31GeographyAPAC7,257,000USD0001200375-25-000006
    Q1 2024Quarterly · 2024-03-31GeographyEMEA2,572,000USD0001200375-25-000006
    Q1 2024Quarterly · 2024-03-31ProductProduct9,551,000USD0001200375-25-000006
    Q1 2024Quarterly · 2024-03-31ProductResearch And Development Revenue7,522,000USD0001200375-25-000006
    FY 2023Yearly · 2023-12-31GeographyAmericas13,733,000USD0001200375-26-000006
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific33,503,000USD0001200375-26-000006
    FY 2023Yearly · 2023-12-31GeographyEMEA22,907,000USD0001200375-26-000006
    FY 2023Yearly · 2023-12-31ProductProduct42,906,000USD0001200375-24-000009
    FY 2023Yearly · 2023-12-31ProductResearchand Development Revenue27,237,000USD0001200375-24-000009
    FY 2023Yearly · 2023-12-31ProductSitagliptin Enzyme700,000USD0001200375-24-000009
    Q3 2023Quarterly · 2023-09-30GeographyAmericas4,278,000USD0001200375-24-000027
    Q3 2023Quarterly · 2023-09-30GeographyAPAC1,808,000USD0001200375-24-000027
    Q3 2023Quarterly · 2023-09-30GeographyEMEA3,191,000USD0001200375-24-000027
    Q3 2023Quarterly · 2023-09-30ProductProduct5,395,000USD0001200375-24-000027
    Q3 2023Quarterly · 2023-09-30ProductResearchand Development Revenue3,882,000USD0001200375-24-000027
    Q1 2023Quarterly · 2023-03-31SegmentNovel Biotherapeutics3,496,000USD0001200375-23-000019
    Q1 2023Quarterly · 2023-03-31SegmentPerformance Enzymes9,486,000USD0001200375-23-000019
    FY 2022Yearly · 2022-12-31GeographyAmericas17,000,000USD0001200375-25-000003
    FY 2022Yearly · 2022-12-31GeographyAsia Pacific65,050,000USD0001200375-25-000003
    FY 2022Yearly · 2022-12-31GeographyEMEA56,540,000USD0001200375-25-000003
    FY 2022Yearly · 2022-12-31ProductEnzyme Product0USD0001200375-23-000012
    FY 2022Yearly · 2022-12-31ProductProduct Sales116,676,000USD0001200375-23-000012
    FY 2022Yearly · 2022-12-31ProductResearchand Development Revenue21,914,000USD0001200375-23-000012
    Q4 2022Quarterly · 2022-12-31SegmentBiotherapeutics4,537,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentCore25,837,000USDLegacy provider
    FY 2022Yearly · 2022-12-31SegmentBiotherapeutics11,978,000USD0001200375-23-000012
    FY 2022Yearly · 2022-12-31SegmentCore126,612,000USD0001200375-23-000012
    Q3 2022Quarterly · 2022-09-30SegmentBiotherapeutic3,324,000USD0001200375-22-000039
    Q3 2022Quarterly · 2022-09-30SegmentCore31,146,000USD0001200375-22-000039
    Q2 2022Quarterly · 2022-06-30SegmentBiotherapeutic1,876,000USD0001200375-22-000032
    Q2 2022Quarterly · 2022-06-30SegmentCore36,530,000USD0001200375-22-000032
    Q1 2022Quarterly · 2022-03-31SegmentNovel Biotherapeutics2,241,000USD0001200375-23-000019
    Q1 2022Quarterly · 2022-03-31SegmentPerformance Enzymes33,099,000USD0001200375-23-000019
    FY 2021Yearly · 2021-12-31GeographyAmericas23,481,000USD0001200375-24-000009
    FY 2021Yearly · 2021-12-31GeographyAsia Pacific61,086,000USD0001200375-24-000009
    FY 2021Yearly · 2021-12-31GeographyEMEA20,187,000USD0001200375-24-000009
    FY 2021Yearly · 2021-12-31ProductProduct70,657,000USD0001200375-24-000009
    FY 2021Yearly · 2021-12-31ProductResearchand Development Revenue34,097,000USD0001200375-24-000009
    Q4 2021Quarterly · 2021-12-31SegmentBiotherapeutics2,383,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31SegmentCore22,117,000USDLegacy provider
    FY 2021Yearly · 2021-12-31SegmentBiotherapeutics14,239,000USD0001200375-23-000012
    FY 2021Yearly · 2021-12-31SegmentCore90,515,000USD0001200375-23-000012
    Q3 2021Quarterly · 2021-09-30SegmentBiotherapeutic4,185,000USD0001200375-22-000039
    Q3 2021Quarterly · 2021-09-30SegmentCore32,584,000USD0001200375-22-000039
    Q2 2021Quarterly · 2021-06-30SegmentBiotherapeutic3,868,000USD0001200375-22-000032
    Q2 2021Quarterly · 2021-06-30SegmentCore21,585,000USD0001200375-22-000032
    FY 2020Yearly · 2020-12-31GeographyAmericas24,352,000USD0001200375-23-000012
    FY 2020Yearly · 2020-12-31GeographyAsia Pacific25,447,000USD0001200375-23-000012
    FY 2020Yearly · 2020-12-31GeographyEMEA19,257,000USD0001200375-23-000012
    FY 2020Yearly · 2020-12-31ProductProduct Sales30,220,000USD0001200375-23-000012
    FY 2020Yearly · 2020-12-31ProductResearchand Development Revenue38,836,000USD0001200375-23-000012
    FY 2020Yearly · 2020-12-31SegmentBiotherapeutics20,950,000USD0001200375-23-000012
    FY 2020Yearly · 2020-12-31SegmentCore48,106,000USD0001200375-23-000012
    FY 2019Yearly · 2019-12-31GeographyAmericas13,039,000USD0001200375-22-000010
    FY 2019Yearly · 2019-12-31GeographyAsia Pacific18,286,000USD0001200375-22-000010
    FY 2019Yearly · 2019-12-31GeographyEMEA37,133,000USD0001200375-22-000010
    FY 2019Yearly · 2019-12-31ProductProduct Sales29,465,000USD0001200375-22-000010
    FY 2019Yearly · 2019-12-31ProductResearchand Development Revenue38,993,000USD0001200375-22-000010
    FY 2019Yearly · 2019-12-31SegmentBiotherapeutics10,302,000USD0001200375-22-000010

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.